TKPHF News and Press, Takeda Pharmaceutical Co Ltd From 09/04/25

2025-09-04 09:03:11 ET More on Novavax Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth Novavax: New Vaccine, Same Old Story - Still A Sell Pfizer, Moderna, Novavax respond to Trump’...

2025-08-15 12:24:05 ET Investment Overview When I last covered Intellia Therapeutics, Inc. ( NTLA ) for Seeking Alpha at the end of May, the share price of the Cambridge, Massachusetts-based pharma company, developing gene therapies using CRISPR technology, was tanking. ...

2025-07-30 11:50:53 ET Takeda Pharmaceutical Company Limited (TAK) Q1 FY2025 Earnings Call July 30, 2025 6:00 A.M. ET Company Participants Furuta - Corporate Participant O’Reilly - Corporate Participant Plump - Corporate Participant Weber - Corporate P...

2025-07-30 03:20:35 ET More on Takeda Pharmaceutical Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector Takeda: Positives And Negatives Offset Each Other Takeda Pharmaceuticals Caps A Strong Year, Guidance Suggests Dividend Is On The Ris...

2025-07-17 11:32:44 ET Intro: A Japanese Pharma Giant Trading in U.S., With Positive Recent News Just in time for what I call "follow-up Friday," I'm following up on a major global pharma stock I covered back in March, who has some interesting news lately that may interest investors...

2025-06-14 10:30:00 ET Despite the war between Israel and Iran that began on June 13 , Amgen's ( AMGN ) stock price continues to hold above its VWAP [volume-weighted average price] and has gained about 15% in the last month.... Read the full article on Seeking ...

2025-06-09 08:45:00 ET ASCO 2025 Overview Prior to the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, I put together a preview article focused on the biotech-related stories coming out of the various oral presentations at the meeting, broken out by disease are...

2025-05-23 12:52:03 ET Summary Despite the lack of cautious enthusiasm from retail investors in Teva, it continues to beat consensus estimates by wide margins and has once again raised its 2025 financial guidance. I highlight Austedo, Uzedy, the launch of biosimilars, and the more...

2025-05-19 12:55:41 ET More on Veeva Systems Veeva: Our 2025 Software Pick Just Keeps Winning Veeva Systems: Substantially Overvalued As Growth Slows Veeva Systems: Staying Buy Rated As VEEV Is Executing Well Biggest stock movers Thursday: JD, KR, MRVL, ZS, a...

2025-05-09 09:26:09 ET Takeda Pharmaceutical Company Limited (TAK) Q4 2024 Results Conference Call May 08, 2025 06:00 AM ET Company Participants Christopher O’Reilly - Head, Investor Relations Christophe Weber - President & Chief Executive Officer Mila...